Bicocca Open Archive

Logo unimib boa
MEREGALLI, CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.471
AS - Asia 16.697
EU - Europa 9.216
SA - Sud America 1.670
AF - Africa 312
OC - Oceania 74
Continente sconosciuto - Info sul continente non disponibili 21
Totale 47.461
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.401
VN - Vietnam 4.936
SG - Singapore 4.857
CN - Cina 2.862
IT - Italia 2.079
HK - Hong Kong 1.565
RU - Federazione Russa 1.410
DE - Germania 1.370
BR - Brasile 1.231
SE - Svezia 942
CA - Canada 884
IE - Irlanda 700
GB - Regno Unito 566
UA - Ucraina 515
IN - India 466
FR - Francia 449
KR - Corea 393
BD - Bangladesh 251
ID - Indonesia 250
FI - Finlandia 241
JP - Giappone 182
TR - Turchia 178
AR - Argentina 168
AT - Austria 160
NL - Olanda 139
IQ - Iraq 127
ES - Italia 113
MX - Messico 110
ZA - Sudafrica 108
PL - Polonia 96
LT - Lituania 88
DK - Danimarca 87
PK - Pakistan 84
CH - Svizzera 71
BE - Belgio 67
SA - Arabia Saudita 63
AU - Australia 57
CO - Colombia 56
EC - Ecuador 56
PH - Filippine 55
VE - Venezuela 54
IR - Iran 53
TW - Taiwan 51
EG - Egitto 39
UZ - Uzbekistan 35
MY - Malesia 34
MA - Marocco 30
PY - Paraguay 30
CL - Cile 29
TN - Tunisia 29
KE - Kenya 27
AE - Emirati Arabi Uniti 26
JO - Giordania 26
TH - Thailandia 26
ET - Etiopia 25
KZ - Kazakistan 25
IL - Israele 24
NP - Nepal 22
OM - Oman 19
RO - Romania 19
EU - Europa 18
AZ - Azerbaigian 16
NZ - Nuova Zelanda 16
BG - Bulgaria 15
PE - Perù 15
BO - Bolivia 14
UY - Uruguay 14
CZ - Repubblica Ceca 13
JM - Giamaica 12
CR - Costa Rica 11
GR - Grecia 11
PS - Palestinian Territory 11
AL - Albania 10
DO - Repubblica Dominicana 10
DZ - Algeria 10
HN - Honduras 10
BH - Bahrain 9
PA - Panama 9
KG - Kirghizistan 8
RS - Serbia 8
NG - Nigeria 7
NI - Nicaragua 7
NO - Norvegia 7
AO - Angola 6
MD - Moldavia 6
PT - Portogallo 6
SY - Repubblica araba siriana 6
SK - Slovacchia (Repubblica Slovacca) 5
KH - Cambogia 4
KW - Kuwait 4
LB - Libano 4
LV - Lettonia 4
MM - Myanmar 4
TT - Trinidad e Tobago 4
BB - Barbados 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
CY - Cipro 3
EE - Estonia 3
GT - Guatemala 3
Totale 47.388
Salva come PNG Salva come JPEG
Città #
Singapore 3.036
Ann Arbor 2.832
Dallas 1.777
Ashburn 1.635
Ho Chi Minh City 1.540
Hong Kong 1.469
San Jose 1.257
Hanoi 1.182
Milan 717
Frankfurt am Main 698
Dublin 677
Chandler 649
Woodbridge 649
Toronto 596
Wilmington 537
New York 517
Los Angeles 487
Jacksonville 464
Dearborn 453
Houston 448
Beijing 418
Fairfield 405
Santa Clara 377
Council Bluffs 306
Chicago 291
Hefei 288
Boardman 285
Seoul 280
Princeton 271
The Dalles 237
Nanjing 200
Seattle 196
Jakarta 175
Shanghai 166
Buffalo 164
Lauterbourg 153
Haiphong 136
Da Nang 135
Cambridge 126
Vienna 125
Moscow 124
Ha Long 118
São Paulo 118
Munich 109
Orem 108
Guangzhou 105
Hải Dương 103
Helsinki 100
Tokyo 98
Biên Hòa 82
Quận Bình Thạnh 81
Dong Ket 74
Lachine 74
Chennai 73
London 70
Rome 70
Lawrence 67
Montreal 67
Nanchang 67
Thái Nguyên 67
Vilnius 67
Ninh Bình 66
Can Tho 65
Bắc Ninh 62
Altamura 61
Vũng Tàu 61
Warsaw 59
Denver 58
Nuremberg 58
Shenyang 56
Atlanta 55
Amsterdam 53
Brooklyn 53
Zurich 53
Baghdad 51
Bắc Giang 51
Johannesburg 51
Phoenix 51
Andover 49
Stockholm 48
Jinan 47
Pune 46
Tianjin 45
Poplar 44
Fremont 43
Quận Một 43
Quận Phú Nhuận 42
Rio de Janeiro 42
Turku 42
Changsha 40
Zhengzhou 40
Brussels 39
Basingstoke 38
Hangzhou 37
Phủ Lý 37
Quận Sáu 37
San Diego 37
San Francisco 37
Baltimore 36
Kent 36
Totale 30.065
Salva come PNG Salva come JPEG
Nome #
Role of ER-mitochondria interaction in the mechanism of chemotherapy-induced peripheral neuropathy 765
Paclitaxel acutely activates ICRAC in sensory neurons: implications for paclitaxel-induced peripheral neuropathy 628
CIPN and its mechanism of development 626
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 580
CHARACTERIZATION OF AXONAL DEGENERATION MECHANISMS IN BORTEZOMIB-TREATED SENSORY NEURONS 544
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 509
SOMETHING NEW ABOUT BORTEZOMIB NEUROTOXICITY 506
Bortezomib-induced peripheral neuropathy: an up-close look at endoplasmic reticulum-mitochondria interaction 500
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 497
INSIGHT ON BORTEZOMIB INDUCED MICROTUBULES STABILITY AND MITOCHONDRIAL TRAFFICKING 485
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 454
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity 446
Paclitaxel activates SOCE/ICRAC in dorsal root ganglion neurons: implications for paclitaxel-induced peripheral neuropathy 443
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 429
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 428
Age-related changes in the function and structure of the peripheral sensory pathway in mice 422
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 420
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 413
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 407
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 399
Tubulin polymerization and mitochondria transport involvement in Bortezomib peripheral neurotoxicity. 397
Effect of age on metabolomic changes in a model of paclitaxel-induced neurotoxicity 390
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 387
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 384
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 382
Microtubule stabilisation and mitochondrial dysfunctions as axonal degeneration mechanisms in bortezomib-treated sensory neurons 375
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 373
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 369
CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON? 360
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 353
A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer 351
ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel 350
Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect 349
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 348
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 347
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy 343
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 336
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 333
Chemotherapy-induced peripheral neuropathy: a focus on ER-mitochondrial interactions 331
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 325
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 320
Blood molecular biomarkers for chemotherapy-induced peripheral neuropathy: From preclinical models to clinical practice 318
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 316
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 313
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats 313
Chemotherapy-induced peripheral neuropathy: a focus on mitochondria and ER- MITOCHONDRIA INTERACTIONS 310
Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection 307
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 307
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 307
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 306
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 306
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 304
Proteasome inhibitors-based chemotherapy induced neurotoxicity: focus on cytoskeleton and mitochondrial dysfunction 302
EVALUATION OF SATELLITE GLIAL CELLS CHANGES IN DORSAL ROOT GANGLIA IN CHEMOTHERAPY-INDUCED NEUROTOXICITY MODELS 301
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 301
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 297
Insight Into Chemotherapeutic-Agents-Induced-Neuroinflammation In Rat Experimental Neuropathies 296
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 296
MSCs ameliorate clinical course in rats with experimental autoimmune encephalomyelitis 294
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 293
Chemotherapy-induced peripheral neuropathy and changes in cytoskeleton 293
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 292
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 290
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 287
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 287
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 284
In vivo study of Carfilzomib-Induced Neuropathy 281
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 280
In vitro morphological study of bortezomib-induced peripheral neurotoxicity 279
Multiple Neuroprotective Mechanisms of Mesenchymal Stem Cells 275
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 274
Effectiveness of MSC therapeutic administration on rats affected by chronic Experimental Autoimmune Encephalomyelitis 273
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 271
Multimodal experimental approach to the study of human neurological diseases 268
MORPHOLOGICAL AND METABOLOMIC CHANGES IN PIPN 265
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 265
Satellite Glial Cells in Chemotherapy Induced Peripheral Neuropathy 264
NEUROINFLAMMATION AS A POTENTIAL TARGET FOR CIPN DIAGNOSTIC AND TREATMENT 262
MSCs effect on Dark Agouti rats affected by chronic EAE 258
Positive effect of Mesenchymal Stem Cells therapeutic administration on chronic Experimental Autoimmune Encephalomyelitis 258
Topiramate in Oxaliplatin-Induced Peripheral Neurotoxicity: more than neuroprotection. 255
Characterization in vivo of two different molecular mechanisms involved in the development of bortezomib-induced peripheral neuropathy 255
MITOCHONDRIAL DYSFUNCTION IS A FEATURE OF PACLITAXEL AND OXALIPLATIN-PROMOTED CHEMOTHERAPY-INDUCED PERIPHERAL NEUROTOXICITY 253
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 253
Different effects of erythropoietin in cisplatin- and docetaxel-induced neurotoxicity: An in vitro study 252
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 250
A new animal model of chemotherapy induced peripheral neurotoxicity : the immunodeficient mouse 250
Transplanted pancreatic islets survive and reverse type I diabetic neuropathy 249
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 249
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 248
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 248
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 247
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 245
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 245
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 244
Inhibition of NHE1 transport activity and gene transcription in DRG neurons in oxaliplatin-induced painful peripheral neurotoxicity 242
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 242
Epothilone B-induced toxic effects on peripheral nervous system: in vitro and in vivo experimental models 242
BEHAVIOURAL AND MORPHOLOGICAL DESCRIPTION OF BORTEZOMIB-INDUCED PAINFUL NEUROPATHY IN RATS 240
PROTEASOME INHIBITORS: IN VITRO MORPHO- FUNCTIONAL CHANGES 238
Totale 33.644
Salva come PNG Salva come JPEG
Categoria #
all - tutte 139.982
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 139.982
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021327 0 0 0 0 0 0 0 0 0 0 0 327
2021/20221.905 161 214 167 180 142 174 84 99 67 121 143 353
2022/20232.954 376 728 332 265 215 481 42 142 219 43 75 36
2023/20242.510 82 64 68 86 329 579 405 114 146 53 45 539
2024/20258.007 419 853 660 428 646 379 511 280 928 1.076 694 1.133
2025/202623.789 4.578 2.430 2.633 1.812 1.951 1.170 2.843 1.109 1.662 1.743 1.312 546
Totale 48.863